Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Velayati

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|June 1, 2012
Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidaseSamarjit Patnaik, Wei Zheng, Jae H Choi, et al.
Journal of Hematology|January 8, 2024
Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World ExperienceAswani Thurlapati, William Wesson, James A Davis, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 3, 2024
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myelomaKelly J Gaffney, Jonathan K Bakos, Arash Velayati, et al.
Annals of Hematology|October 18, 2023
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myelomaJames A Davis, Aswani Thurlapati, Erin Weeda, et al.
International Journal of Colorectal Disease|May 17, 2011
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patientsReza Raeisossadati, Moein Farshchian, Azita Ganji, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Journal of Medicinal Chemistry|July 28, 2012
Discovery of a novel noniminosugar acid α glucosidase chaperone seriesJingbo Xiao, Wendy Westbroek, Omid Motabar, et al.
Blood Cancer Journal|April 4, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapyMasooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen, et al.
Blood|July 8, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple MyelomaHitomi Hosoya, Arash Velayati, Danai Dima, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|June 1, 2012
Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidaseSamarjit Patnaik, Wei Zheng, Jae H Choi, et al.
Journal of Hematology|January 8, 2024
Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World ExperienceAswani Thurlapati, William Wesson, James A Davis, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 3, 2024
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myelomaKelly J Gaffney, Jonathan K Bakos, Arash Velayati, et al.
Annals of Hematology|October 18, 2023
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myelomaJames A Davis, Aswani Thurlapati, Erin Weeda, et al.
International Journal of Colorectal Disease|May 17, 2011
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patientsReza Raeisossadati, Moein Farshchian, Azita Ganji, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Journal of Medicinal Chemistry|July 28, 2012
Discovery of a novel noniminosugar acid α glucosidase chaperone seriesJingbo Xiao, Wendy Westbroek, Omid Motabar, et al.
Blood Cancer Journal|April 4, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapyMasooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen, et al.
Blood|July 8, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple MyelomaHitomi Hosoya, Arash Velayati, Danai Dima, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Pageof 5